A recent study across cancer types, including melanoma, indicated that an elevated frequency of CD8+ T‐cells within the stroma and invasive margin compartments had a better outcome than those in intra‐tumor compartments (Chen & Mellman, 2017; Li et al, 2021). This evidence concerns the gene CD8A and neoplasm.